ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]1996
Molecular aspects of osteoclast function.
Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Histological assessment of the local effect of different concentrations of aminoguanidine hydrochloride on bone healing in rats.Dental research journal · 2021Article
- Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.International journal of oral science · 2015Article
- Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone loss.Molecular oral microbiology · 2012Article
- Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.Gene therapy · 2011Article
- Regulation of osteoclast polarization.Odontology · 2007Review
- Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors.Molecular biology of the cell · 2006Article
- Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.Theoretical biology & medical modelling · 2005Review
- A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.The Journal of clinical investigation · 2000Article
- The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.The Journal of cell biology · 1999Article
- Bacterially induced bone destruction: mechanisms and misconceptions.Infection and immunity · 1996Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article we have overviewed recent important advances in understanding the molecular mechanisms involved in osteoclastic bone resorption. Specifically, new findings relating to osteoclast activation and the process of bone resorption are reviewed and a current overall model of how osteoclasts resorb bone is presented. Controversial research topics concerning the regulation of osteoclast activity are also critically discussed.
Indexed as
Identifiers
8821771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.